Events
26.10.2020

Cromos Pharma at GRx+Biosims November 9-11, 2020

We are delighted to be taking part in the upcoming GRx+Biosims 2020 virtual conference (9-11 Nov). 
GRx-2_1.png

COVID-19 and its economic impacts have only strengthened the rationale for the development of a strong biosimilar market as health systems seek to reduce costs and make life-changing treatments available to patients across broader regions of the globe.

At Cromos Pharma, we have extensive experience and expertise in managing early and late phase clinical trials for biosimilars by facilitating efficient and effective patient recruitment and retention across our operations in Eastern Europe and CIS Region. We are also experienced in design and management of the initial Phase I studies in healthy volunteers and can offer Cromos-coordinated support of our preferred biosimilar partners, uniquely experienced Phase I units in EU, US and Australia. 


Our COO, Stephanie Finnegan would be delighted to fill you in on the specific benefits of working with Cromos Pharma and discuss opportunities for collaboration on your next biosimilar program. Email us at bd@cromospharma.com to set up a time for a virtual meeting.  Steph.png  

Remember to follow and post updates relating to the event by using #GRxBiosims

Twitter

LinkedIn


Other Events:
news

Connect with Cromos Pharma at MAGI's Clinical Research vConference

Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).

17.09.2020
news

Join us at Bio in Philadelphia on June 3-6, 2019

16.05.2019
news

Meet us at Asco Annual Meeting 2019 In Chicago, USA on May 31 – June 4, 2019

13.05.2019
news

Meet us at the 11th Dia China Annual Meeting 2019 in Beijing, China on 20-23 May, 2019

30.04.2019
news

Join Cromos™ Pharma at the 12th European Biosimilars Congress in Berlin, Germany on 15-16 April, 2019

26.03.2019
news

2019 J.P. Morgan 37th Annual Healthcare Conference

10.12.2018